194 related articles for article (PubMed ID: 22622007)
21. Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses.
Salem ML
Immunol Lett; 2011 Jun; 137(1-2):9-14. PubMed ID: 21352854
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptors and NOD-like receptors in rheumatic diseases.
McCormack WJ; Parker AE; O'Neill LA
Arthritis Res Ther; 2009; 11(5):243. PubMed ID: 19835640
[TBL] [Abstract][Full Text] [Related]
23. Differences in the repertoire, regulation and function of Toll-like Receptors and inflammasome-forming Nod-like Receptors between human and mouse.
Ariffin JK; Sweet MJ
Curr Opin Microbiol; 2013 Jun; 16(3):303-10. PubMed ID: 23540353
[TBL] [Abstract][Full Text] [Related]
24. NOD-like receptors: role in innate immunity and inflammatory disease.
Chen G; Shaw MH; Kim YG; Nuñez G
Annu Rev Pathol; 2009; 4():365-98. PubMed ID: 18928408
[TBL] [Abstract][Full Text] [Related]
25. Activating immunity: lessons from the TLRs and NLRs.
Monie TP; Bryant CE; Gay NJ
Trends Biochem Sci; 2009 Nov; 34(11):553-61. PubMed ID: 19818630
[TBL] [Abstract][Full Text] [Related]
26. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
[TBL] [Abstract][Full Text] [Related]
27. Innate immune mechanism in allergic asthma.
Suarez CJ; Parker NJ; Finn PW
Curr Allergy Asthma Rep; 2008 Sep; 8(5):451-9. PubMed ID: 18682113
[TBL] [Abstract][Full Text] [Related]
28. Mannose-binding lectin and innate immunity.
Ip WK; Takahashi K; Ezekowitz RA; Stuart LM
Immunol Rev; 2009 Jul; 230(1):9-21. PubMed ID: 19594626
[TBL] [Abstract][Full Text] [Related]
29. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
30. Human macrophage host defense against Mycobacterium tuberculosis.
Liu PT; Modlin RL
Curr Opin Immunol; 2008 Aug; 20(4):371-6. PubMed ID: 18602003
[TBL] [Abstract][Full Text] [Related]
31. Modulating immunity as a therapy for bacterial infections.
Hancock RE; Nijnik A; Philpott DJ
Nat Rev Microbiol; 2012 Mar; 10(4):243-54. PubMed ID: 22421877
[TBL] [Abstract][Full Text] [Related]
32. Understanding and activating immunity against human cancer.
Stevenson FK; Palucka K
Curr Opin Immunol; 2010 Apr; 22(2):212-4. PubMed ID: 20338741
[No Abstract] [Full Text] [Related]
33. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
34. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.
Melief CJ; Van Der Burg SH; Toes RE; Ossendorp F; Offringa R
Immunol Rev; 2002 Oct; 188():177-82. PubMed ID: 12445291
[TBL] [Abstract][Full Text] [Related]
35. SR-A/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens.
Mukhopadhyay S; Varin A; Chen Y; Liu B; Tryggvason K; Gordon S
Blood; 2011 Jan; 117(4):1319-28. PubMed ID: 21098741
[TBL] [Abstract][Full Text] [Related]
36. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
Jäger E; Jäger D; Knuth A
Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
[No Abstract] [Full Text] [Related]
37. Dendritic cell-based cancer immunotherapies.
Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
[TBL] [Abstract][Full Text] [Related]
38. Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs.
Istomin AY; Godzik A
BMC Immunol; 2009 Sep; 10():48. PubMed ID: 19728889
[TBL] [Abstract][Full Text] [Related]
39. Pathogen recognition by the innate immune system.
Kumar H; Kawai T; Akira S
Int Rev Immunol; 2011 Feb; 30(1):16-34. PubMed ID: 21235323
[TBL] [Abstract][Full Text] [Related]
40. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
